EUVIMEDEUVIMED entdecken
Klinische Studie (Phase IV)Multizentrische StudieRandomisierte kontrollierte StudieOpen Access

Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial

Joong Min Lee, Min Soo Cho, Do-Yoon Kang, Jung-Min Ahn, Yong-Seog Oh, Chang Hoon Lee, Eue-Keun Choi, Ji Hyun Lee, Chang Hee Kwon, Gyung-Min Park, Hyung Oh Choi, Kyoung-Ha Park und 12 weitere

EuroIntervention · 2026-04 · 22 (8) · e432-e443

DOI: 10.4244/eij-d-25-01274 ↗

Kurz gefasst

Klinische Studie (Phase IV) in der Zeitschrift EuroIntervention, 2026-04. Verfasst von Joong Min Lee und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. Hauptthemen laut MEDLINE: Atrial Fibrillation, Coronary Artery Disease, Factor Xa Inhibitors, Fibrinolytic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Renal function is a critical factor of ischaemic and bleeding risks in patients with atrial fibrillation (AF) receiving antithrombotic therapy. AIMS: This study aimed to evaluate the impact of renal dysfunction in patients with AF and stable coronary artery disease (CAD) undergoing antithrombotic therapy. METHODS: The Edoxaban Versus Edoxaban With antiPlatelet Agent In Patients With Atrial Fibrillation and Chronic Stable Coronary Artery Disease (EPIC-CAD) trial randomised patients to edoxaban monotherapy or dual antithrombotic therapy (edoxaban plus a single antiplatelet agent). In this prespecified analysis, patients were stratified by creatinine clearance into low (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCoronary Artery DiseaseFactor Xa InhibitorsFibrinolytic AgentsKidneyPlatelet Aggregation InhibitorsPyridinesThiazolesAgedFemaleHumansMaleMiddle AgedHemorrhageTreatment Outcome

Substanzen

edoxabanFactor Xa InhibitorsFibrinolytic AgentsPlatelet Aggregation InhibitorsPyridinesThiazoles

Autor:innen und Institutionen

  • Department of Cardiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Seoul St. Mary's Hospital, College of Medicine, Catholic University of Korea, Seoul, South Korea.
  • Department of Cardiology, Veterans Health Service Medical Center, Seoul, South Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, South Korea.
  • Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam, South Korea and National University College of Medicine, Seongnam, South Korea.
  • Division of Cardiology, Department of Internal Medicine, Konkuk University Medical Center, Konkuk University School of Medicine, Seoul, South Korea.

Zitieren

APA

Lee, J. M., Cho, M. S., Kang, D. Y., Ahn, J. M., Oh, Y. S., Lee, C. H., Choi, E. K., Lee, J. H., Kwon, C. H., Park, G. M., Choi, H. O., Park, K. H., Park, K. M., Hwang, J., Yoo, K. D., Cho, Y. R., Kim, J. H., Hwang, K. W., Jin, E. S., …, & Park, D. W. (2026). Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial. EuroIntervention, 22(8), e432-e443. https://doi.org/10.4244/eij-d-25-01274

Vancouver

Lee JM, Cho MS, Kang DY, Ahn JM, Oh YS, Lee CH, et al. Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial. EuroIntervention. 2026;22(8):e432-e443. doi:10.4244/eij-d-25-01274

BibTeX
@article{Lee2026,
  author = {Lee, Joong Min and Cho, Min Soo and Kang, Do-Yoon and Ahn, Jung-Min and Oh, Yong-Seog and Lee, Chang Hoon and Choi, Eue-Keun and Lee, Ji Hyun and Kwon, Chang Hee and Park, Gyung-Min and Choi, Hyung Oh and Park, Kyoung-Ha and Park, Kyoung-Min and Hwang, Jongmin and Yoo, Ki-Dong and Cho, Young-Rak and Kim, Ji Hyun and Hwang, Ki Won and Jin, Eun-Sun and Kwon, Osung and Kim, Ki-Hun and Park, Seung-Jung and Nam, Gi-Byoung and Park, Duk-Woo},
  title = {Impact of renal function on edoxaban antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease: a prespecified analysis of the EPIC-CAD trial},
  journal = {EuroIntervention},
  year = {2026},
  volume = {22},
  number = {8},
  pages = {e432--e443},
  doi = {10.4244/eij-d-25-01274}
}
Kostenlos starten →